THERAPY-RELATED MYELODYSPLASTIC SYNDROME FOLLOWING CYCLOPHOSPHAMIDE PULSE AND/OR METHOTREXATE THERAPY IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS-Reference-Cited by-同舟云学术

THERAPY-RELATED MYELODYSPLASTIC SYNDROME FOLLOWING CYCLOPHOSPHAMIDE PULSE AND/OR METHOTREXATE THERAPY IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Published:2010 Issue:2 Volume:56 Page:121-127
ISSN:0016-2590
Container-title:FUKUSHIMA JOURNAL OF MEDICAL SCIENCE
language:en
Short-container-title:FJMS

Author:

IWADATE HARUYO¹,KOBAYASHI HIROKO¹,YANO KIORI¹,WATANABE HIROSHI¹,IKEDA KAZUHIKO²,OGAWA KAZUEI²,OHIRA HIROMASA¹

Affiliation:

1. Department of Gastroenterology and Rheumatology, Fukushima Medical University School of Medicine

2. Department of Cardiology and Hematology, Fukushima Medical University School of Medicine

Publisher

The Fukushima Society of Medical Science

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/fms/56/2/56_2_121/_pdf

Reference37 articles.

1. 1. Kantarjian HM, Keating MJ, Walters RS, Smith TL, Cork A, McCredie KB, et al. Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features. J Clin Oncol, 4: 1748-1757, 1986.

2. 2. Michels SD, McKenna RW, Arthur DC, Brunning RD. Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases. Blood, 65: 1364-1372, 1985.

3. 3. McCarthy CJ, Sheldon S, Ross CW, McCune WJ. Cytogenetic abnormalities and therapy-related myelodysplastic syndromes in rheumatic disease. Arthritis Rheum, 41: 1493-1496, 1998.

4. 4. Rosenthal NS, Farhi DC. Myelodysplastic syndromes and acute myeloid leukemia in connective tissue disease after single-agent chemotherapy. Am J Clin Pathol, 106: 676-679, 1996.

5. 5. Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. WHO Classification of Tumours. In: Pathology & Genetics. A. IARC Press, Lyon, 270-271, 2001.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematologic Toxicity of Drug Therapy;Comprehensive Dermatologic Drug Therapy;2021

2. Usefulness of tocilizumab for treating rheumatoid arthritis with myelodysplastic syndrome;Medicine;2018-06